DE60040792D1 - Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene - Google Patents

Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene

Info

Publication number
DE60040792D1
DE60040792D1 DE60040792T DE60040792T DE60040792D1 DE 60040792 D1 DE60040792 D1 DE 60040792D1 DE 60040792 T DE60040792 T DE 60040792T DE 60040792 T DE60040792 T DE 60040792T DE 60040792 D1 DE60040792 D1 DE 60040792D1
Authority
DE
Germany
Prior art keywords
cellular
pathogenes
protein
stress
peptide complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040792T
Other languages
English (en)
Inventor
Camilo Anthony Colaco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunobiology Ltd
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of DE60040792D1 publication Critical patent/DE60040792D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE60040792T 1999-08-19 2000-08-18 Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene Expired - Lifetime DE60040792D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919733.7A GB9919733D0 (en) 1999-08-19 1999-08-19 Vaccines against intracellular pathogens
PCT/GB2000/003225 WO2001013943A2 (en) 1999-08-19 2000-08-18 Stress protein-peptide complexes as vaccines against intra cellular pathogens

Publications (1)

Publication Number Publication Date
DE60040792D1 true DE60040792D1 (de) 2008-12-24

Family

ID=10859500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040792T Expired - Lifetime DE60040792D1 (de) 1999-08-19 2000-08-18 Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene

Country Status (14)

Country Link
EP (1) EP1204421B1 (de)
JP (1) JP2003527322A (de)
CN (1) CN1182871C (de)
AT (1) ATE413887T1 (de)
AU (1) AU6709700A (de)
CA (1) CA2382331C (de)
DE (1) DE60040792D1 (de)
DK (1) DK1204421T3 (de)
ES (1) ES2316380T3 (de)
GB (1) GB9919733D0 (de)
IL (2) IL148154A0 (de)
PT (1) PT1204421E (de)
WO (1) WO2001013943A2 (de)
ZA (1) ZA200201357B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) * 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888053A4 (de) * 1995-08-18 2002-07-31 Sloan Kettering Inst Cancer Verfahren zur behandlung von krebs und infektionskrankheiten und dafür verwendbare zusammensetzungen
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
JPH11513369A (ja) * 1995-09-13 1999-11-16 フォーダム ユニバーシティー 熱ショックタンパク質を用いる治療及び予防方法
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US6130087A (en) * 1996-10-07 2000-10-10 Fordham University Methods for generating cytotoxic T cells in vitro
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine

Also Published As

Publication number Publication date
EP1204421B1 (de) 2008-11-12
WO2001013943A2 (en) 2001-03-01
CA2382331A1 (en) 2001-03-01
JP2003527322A (ja) 2003-09-16
PT1204421E (pt) 2009-03-18
WO2001013943A3 (en) 2001-09-20
ATE413887T1 (de) 2008-11-15
CN1370077A (zh) 2002-09-18
ES2316380T3 (es) 2009-04-16
ZA200201357B (en) 2003-07-30
EP1204421A2 (de) 2002-05-15
AU6709700A (en) 2001-03-19
CA2382331C (en) 2011-06-14
IL148154A (en) 2008-11-26
GB9919733D0 (en) 1999-10-20
DK1204421T3 (da) 2009-03-09
IL148154A0 (en) 2002-09-12
CN1182871C (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
IL172189A0 (en) Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
EA200500584A1 (ru) Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
PL330407A1 (en) Substituted cyclopentane compounds useful as neuraminidaze inhibitors
AU2002360592A8 (en) Inhibitors of hepatitis c virus
HK1079705A1 (zh) 包含用於治療癌症及感染性疾病的熱休克蛋白或α2-巨球蛋白的組合物製備方法
MXPA05006196A (es) Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
ATE402715T1 (de) Hcv-impfstoff zusammensetzungen
NO20055750L (no) Nye kjemiske forbindelser
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
DE60336068D1 (de) Antikörper gerichtet gegen oxidierten Apolipoprotein B
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
DE60040792D1 (de) Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
TW200612983A (en) Vaccine
WO2003053332A3 (en) Composition and method for treating viral infection
SE9903534D0 (sv) Vaccin
ATE449610T1 (de) Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
WO2005010035A3 (en) Alternate reading frame polypeptides derived from hepatitis c and methods of their use
SE0202959D0 (sv) Peptide-Base passive immunization therapy for treatment of atherosclerosis

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MURGITROYD & COMPANY, 48149 MUENSTER

8364 No opposition during term of opposition